欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/2184/005
药品名称
Risperdal 3 mg
活性成分
Risperidone 3.0 mg
剂型
Film-coated tablet
上市许可持有人
Janssen-Cilag GmbH Johnson & Johnson Platz 1 41470 Neuss Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Belgium (BE)
Austria (AT)
Risperdal 3 mg Filmtabletten
Italy (IT)
Poland (PL)
Rispolept
Slovenia (SI)
Czech Republic (CZ)
Cyprus (CY)
Estonia (EE)
RISPOLEPT 3 mg
Lithuania (LT)
Rispolept 3 mg plėvele dengtos tabletės
Latvia (LV)
Finland (FI)
Norway (NO)
Sweden (SE)
Greece (EL)
Portugal (PT)
Ireland (IE)
Iceland (IS)
Luxembourg (LU)
Netherlands (NL)
Denmark (DK)
Malta (MT)
Spain (ES)
许可日期
2010/04/28
最近更新日期
2025/05/16
药物ATC编码
N05AX08 risperidone
申请类型
TypeLevel1：
TypeLevel2：
TypeLevel3：
TypeLevel4：
TypeLevel5：
附件文件下载
Final Product Information
|
common_final_combined_2184_V080
Date of last change:2024/09/06
Final Labelling
|
DE2184_02_07_R01_Risperdal FT_common_interpack_clean_20140616_renewal
Date of last change:2024/09/06
Final PL
|
DE2184_02_12_16_R01_Risperdal_common_pl_clean_oral_20140616_renewal
Date of last change:2024/09/06
Final SPC
|
DE2184_02_12_16_R01_Risperdal_common_smpc_clean_oral_20140616_renewal
Date of last change:2024/09/06
Final Labelling
|
DE2184_08_R01_Risperdal oral solution_common_interpack_clean_20140616_renewal
Date of last change:2024/09/06
Final Labelling
|
DE2184_09_12_16_R01_Risperdal Quicklet_common_interpack_clean_20140616_renewal
Date of last change:2024/09/06
Final Labelling
|
DE2184_13_15_R01_Risperdal Consta_common_interpack_clean_20140616_renewal
Date of last change:2024/09/06
Final PL
|
DE2184_13_15_R01_Risperdal Consta_common_pl_clean_consta_20140616_renewal
Date of last change:2024/09/06
Final SPC
|
DE2184_13_15_R01_Risperdal Consta_common_smpc_clean_consta_20140616_renewal
Date of last change:2024/09/06
市场状态
Positive
©2006-2026
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase